AtCor Medical has said that it has developed its new, more compact SphygmoCor systems, available in different configurations, to make assessing central blood pressure, pulse wave velocity and heart rate variability easier and more convenient in settings where space is at a premium – at bedside in hospitals, in patient exam rooms in physicians’ offices, ERs, mobile patient screening vans, and in home care. All three tests are used in evaluating cardiovascular status and in managing patient care.
The new SphygmoCor systems, approximately 25% the size and weight of AtCor’s first generation systems, offer the same functionality as the company’s earlier SphygmoCor Px and Vx systems with added portability, less power consumption and enhanced electronics, the company said.
According to the company, the SphygmoCor CPV system, which performs both central blood pressure and pulse wave velocity assessments, can also be configured to perform heart rate variability analyses, a new system capability.